A new study looked at 32 critically ill COVID-19 patients who were placed on ECMO machines at nine different hospitals and found that 68% were still alive at the time of analysis.

Britain's most senior doctors have demanded immediate Government action to tackle soaring fatalities from Covid-19 in black and Asian communities, the Mail on Sunday can reveal.

Two hospitals, in New York and California, are giving male coronavirus patients sex hormones found mainly in women to see if they reduce inflammation and the severity of the illness.

Six counties in the San Francisco Bay Area say that masks with one-way valves do not meet their face covering requirements because they allow potentially infectious droplets to excape.

A new study led by Wuhan University in China has found that people with blood and lung cancers are three times more likely to die from coronavirus compared patients with other tumors.

A new review article, from the Massachusetts Institute of Technology, finds that mucosal cells are 'stiffer' in older patients due to more protein fibers, allowing coronavirus to multiply more easily.

Yale University will begin a clinical trial to test the safety and effectiveness of asthma drug ibudilast after it was found to reduce lung inflammation caused by coronavirus in mouse models.

A new study from the University of Notre Dame has found that maintaining a high level of social distancing until summer 2020 allowed for tapering of control of the virus later on.

A new study from the University of Texas at Austin found that antibodies produced by llamas bind to proteins found on the coronavirus and prevent them from infecting cells.

Researchers at Saarland University in Homburg, Germany, say that with a sensitive enough tests, they can detect just one positive in a single test tube samples taken from 30 patients.

Cardiologist Dr Robert Bonow says that in the US as well as Italy and China, coronavirus has attached itself to the hearts of infected people and even triggered heart attacks due to severe inflammation.

A new study from Penn Vet will have eight dogs be exposed to COVID-19 positive saliva and urine samples and then test if they can discriminate between positive and negative samples.

Preliminary results of New York state testing of hydroxychloroquine to treat some 600 coronavirus patients suggest those treated with the drug fare no better than those who did not receive it.

A small French study has found that severely ill coronavirus patients given tocilizumab, a drug used to treat rheumatoid arthritis, were less likely to be put on life support and less likely to die.

Antigen tests are easier and cheaper to manufacture and simpler to administer because they require specific chemicals, highly-trained staff or specialized equipment unlike current tests.

Between 20 and 40 percent of COVID-19 patients at Emory University in Atlanta, Georgia, have developed blood clots - even after being put on blood thinners, doctors there say.

Social media is awash with data and graphs, which all seem to point to the same grim conclusion: that the UK is one of worst affected countries, with our virus death toll approaching a chilling 30,000.

Two hormone treatments used in prostate cancer patients will be available before chemotherapy, as hospitals try to keep patients away from hospitals during the coronavirus crisis.

The adult entertainment industry launched an STI testing and contact tracing program, like what's needed for coronavirus, to stop the spread of HIV. It hasn't been transmitted on regulated sets since 2004.

Dermatologists have warned of five skin conditions after studying 375 patients. The most common, affecting half, was a rash of either flat or raised bumps

A Harvard University review found issues with each of 10 studies on hydroxychloroquine they examined. The drug can be immunosuppressive, which could be helpful or harmful for covid patients.

Data from a project led by University of Oxford researchers shows that Britain's rate of 394 deaths per million is the fourth worst in world behind Italy, Spain and Belgium.

The map, created by the Office for National Statistics, shows deprived regions in England and Wales are suffering 55 deaths per 100,000 people, compared to 25 deaths in affluent areas.

Dr Paul Hunter, a medicine lecturer at the University of East Anglia, said it was 'valid' for people to be tested more than once and that tests are not perfect so may have to be repeated.

More than 90% of COVID-19 patients treated with hydroxychloroquine in studies in France and Boston had longer than normal pauses in their heart beats - a sign of dangerous arrhythmias.

Evidence suggests the biggest risk factor for death by Covid-19 is age, but scores of pensioners are bucking the trend by managing to shake off the killer infection.

As a person ages, their immune system becomes suppressed and it takes longer for their body to recognise and attack the virus. Harvard scientists say this could be fixed by with NAD boosters.

DR ELLIE CANNON reveals how the oximeter, pictured, a simple tool available easily on the high street, can help catch Covid-19 before it turns deadly.

Charities in the UK have warned the killer infection can lead to acute kidney injury (AKI), a sudden serious condition that can be fatal if not treated immediately.

Dr Giorgio Gentile gave Leonard Whitehurst, being treated at Royal Cornwall Hospital, the drug tocilizumab as a last ditch attempt to save his life. He had heard promising results from early trials.

Top experts from the prestigious Royal Society concluded that masks - even home-made ones - can reduce the transmission of the deadly infection.

Swiss drug maker Roche says its coronavirus antibody blood test has a specificity rate of 99.8% and a sensitivity of 100%, meaning it would show very few false positives and no false negatives

New research has shown that our response to infection changes over the course of each day, and - even more importantly - that sleep disruption can leave our immune system compromised (file photo).

A new study from Rush University Medical Center looked at the protein, known as suPAR, is a marker of disease severity and aggressiveness as well as activating of the immune system.

History shows how lethal disease pandemics have a habit of seeming to shrink away - but then returning suddenly in subsequent waves. Chillingly, these latter waves can prove far deadlier.

Leronlimab is a drug in development for treating HIV and cancer. Two of seven critically ill coronavirus patients who were given the drug were taken off ventilators in a matter of days.

One sample collected from an Arizona coronavirus patient showed a deletion of 81 genetic 'letters' that suppresses the virus's ability to fight the human immune system, also seen as SARS began to fade.

Researchers at the London School of Economics have highlighted exactly where the UK has fallen short of protecting some 400,000 care home residents and staff.

An urgent review has been launched by Health Secretary Matt Hancock into whether obesity, ethnicity and gender raise the risk of death from coronavirus.

Defra confirmed it is conferring with scientists about whether wastewater can help trace the spread of the deadly infection. It could become part of the government's plan to ease Britain out of lockdown.

Sir Patrick Vallance told MPs on the Health and Social Care Select Committee that masks could have a 'marginal but positive' impact on curbing transmission of the life-threatening infection.

Leading genetic scientists analysed the genomes of the killer virus in 260 infected patients from all corners of the UK. They say they have identified 12 unique mutations (shown).

In the new survey, from PR firm Bospar, researchers found those between ages 18 and 24 were the least likely to get vaccinated against the coronavirus with only 57.8% saying they'd get the jab.

Researchers at Los Alamos National Laboratory have discovered a mutation to the coronavirus's spike protein that may make it more infectious - and it has spread around the globe.

British researchers modelled how the virus would spread in three scenarios - if Italy stayed in quarantine or if movement returned to pre-lockdown levels by 20% and 40% (shown in red).

Researchers from the University of Sheffield and Los Alamos National Laboratory in New Mexico found that a newer, faster-spreading version of the virus seems to edge out the older type.

The UK's death toll (29,427) surpassed Italy's (29,315) today, meaning it is the worst-hit nation on the continent. But, even now, Britain's borders remain open, making it a global outlier.

The president of the Hospital Consultants and Specialists Association said Britain's testing and tracing has been 'inadequate' and questions should be asked about the timing of lockdown.

Researchers from Germany and the US explained fat cells secrete ACE-2 receptors - known as the 'gateway' into the cells of the body.

Just yesterday University of Sheffield researchers claimed that a new, more infectious type of COVID-19 had been racing through Europe. But the finding was today dismissed as 'unfounded'.